Abstract:BACKGROUND: Infection is a common cause of acute lung injury (ALI). This study was aimed to explore whether Toll-like receptors 4 (TLR4) of airway smooth muscle cells (ASMCs) play a role in lipopolysaccharide (LPS)-induced airway hyperresponsiveness and potential mechanisms.METHODS: In vivo: A sensitizing dose of LPS (50 µg) was administered i.p. to female mice before anesthesia with either 3% sevoflurane or phenobarbital i.p. After stabilization, the mice were challenged with 5 µg of intratracheal LPS to mimic inflammatory attack. The effects of sevoflurane were assessed by measurement of airway responsiveness to methacholine, histological examination, and IL-1, IL-6, TNF-α levels in bronchoalveolar lavage fluid (BALF). Protein and gene expression of TLR4 and NF-κB were also assessed. In vitro: After pre-sensitization of ASMCs and ASM segments for 24h, levels of TLR4 and NF-κB proteins in cultured ASMCs were measured after continuous LPS exposure for 1, 3, 5, 12 and 24h in presence or absence of sevoflurane. Constrictor and relaxant responsiveness of ASM was measured 24 h afterwards.RESULTS: The mRNA and protein levels of NF-κB and TLR4 in ASM were increased and maintained at high level after LPS challenge throughout 24h observation period, both in vivo and in vitro. Sevoflurane reduced LPS-induced airway hyperresponsiveness, lung inflammatory cell infiltration and proinflammatory cytokines release in BALF as well as maximal isometric contractile force of ASM segments to acetylcholine, but it increased maximal relaxation response to isoproterenol. Treatment with specific NF-κB inhibitor produced similar protections as sevoflurane, including decreased expressions of TLR4 and NF-κB in cultured ASMCs and improved pharmacodynamic responsiveness of ASM to ACh and isoproterenol.CONCLUSIONS: This study demonstrates the crucial role of TLR4 activation in ASMCs during ALI in response to LPS. Sevoflurane exerts direct relaxant and anti-inflammatory effects in vivo and in vitro via inhibition of TLR4/NF-κB pathway.

Regulation of Sevoflurane on Immune Factors

Effect of sevoflurane on learning and memory and related mechanisms

The Effect of Sevoflurane on the Cognitive Function of Rats and Its Association with the Inhibition of Synaptic Transmission.

Effects of Hippocampal Na+-K+-2C1- Cotransporter on Sevoflurane-Induced Neurobehavioral Impairments in Neonatal Rats

Progress in the Research of Relationship between Anesthesia and Inflammatory Regulation

Progression in the study of protective effect of microRNAs against sevoflurane-induced postoperative cognitive dysfunction and potential mechanisms

Effects of inhalation of different concentrations of sevoflurane on pulmonary inflammatory response in rats

IL-17A is a Key Regulator of Neuroinflammation and Neurodevelopment in Cognitive Impairment Induced by Sevoflurane

Research on Mechanism of Sevoflurane Carried with Superparamagnetic Iron Oxide Nanoparticles in Regulating Metabolism and Function of Anterior Cervical Lymphocytes Through Induction of PI3K/AKT Signal Pathway

Protective Mechanism of Sevoflurane Against Cerebral Ischemia-Reperfusion Induced Injury

Sevoflurane Inhibits Nuclear Factor-κB Activation in Lipopolysaccharide-Induced Acute Inflammatory Lung Injury via Toll-Like Receptor 4 Signaling

Similarity and dissimilarity in alterations of the gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane

Sevoflurane-induced inflammation development: involvement of cholinergic anti-inflammatory pathway.

An analysis of the safety of Sevoflurane drugs: A disproportionality analysis based on Food and Drug Administration Adverse Event Reporting System

Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages

Study on the effect of sevoflurane on the cognitive function of aged rats based on the activation of cortical microglia

Sevoflurane alleviates liver ischemia reperfusion injury through inactivation of the TRAF6/NF-κB signaling pathway

The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways

Recent Progress in Neuroprotective Effects of Sevoflurane Preconditioning:Molecular Mechanisms

Research progress in the clinical application of inhaled anesthetic sevoflurane

Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia